Clinical Trials Search at Vanderbilt-Ingram Cancer Center
GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
Hematologic
Hematologic
The purpose of this study is to assess the efficacy and safety of itacitinib in combination with corticosteroids as first-line treatment for moderate or severe chronic graft-versus-host disease (cGVHD).
Hematologic
III
Kitko, Carrie
NCT03584516
VICCCTT1910
